Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Has Marzan sold his shares or is he just tired of following this BB? Any of his minions know where he is at?
No company in their right mind will pay more than double the current market cap.
Don’t dance around it. Own it buddy!
Why keep it behind closed doors. That only helps the bidders. Throw the doors wide open to all when the time is right to put this into auction mode for all to come and kick the tires and put in their bid! Definitely do not do this behind closed doors
I might be persuaded to accept $10 cash PLUS 1 Merck share for every 4 NWBO shares. in a Merck BO.
I suggest we not go there. The mere suggestion that the shorts may be able to cap share price even in the face of really good news could be a self fulfilling prophecy that lowers the number of buyers out of fear of a repeat of May 10. and thus helps to depress the price. So I would suggest that speculation on this issue is exactly what the shorts hope to encourage. It can only help them.
Thanks Atl, I knew this was coming, but never heard it quite so directly as now. Nov 20 will not disappoint.
Right on. It is a waste of time to post about him. He is the face and the posterboy for the real movers and shakers who prefer to stay in the dark and happy to hide behind AF.
Let me amend that. They won't bother to bring suit if he is the ONLY named defendant. They may name as a codefendant in a suit hat goes after the major villains in this piece.
Even some of the former shorts who did make out very well at the expense of both patients and investors, may yet have a day of reckoning in court in the not too distant future. So spend it while you can.
I am starting to think that the long awaited one-two-three-punch that NWBO has promised is about to come. I had thought that the various PRs would be more drawn out over a couple of months or more, I now believe it will all be very short and quick with a rat-a-tat machine gun rapidity in say the 14 day (or less) period mostly between the Nov 11 SNO abstract release and the Nov 20 presentation. I believe the Nov 20 date will be the kiss of death for the shorts. there is very little volume that they do not create as the volume is low and most longs are holding tight. They will have to suffer huge losses and perhaps really try high volume shorting to manage the price which they will finally fail to be able to do. If I were a short I would be quaking in my boots as they are quite smart and know what is coming their way, curtesy of LP and her policy of silence (as much as I hated that policy). I do believe that the Nov 20 date is part of the master plan. the abstract as we shall see is NOT a placeholder. That will be the definitive give away thatt Nov 20 is deadly serious. I fully expect some (more than one) piece of good news and several PRs in the final lead up to Nov 20. I have no idea what the news will be, whether the JA, the announcement of the ASM, the TLD with elaboration, news of a BLA, MAA, MIA and the whole alphabet soup of possibilities. probably in the UK and maybe in the USA as well, or partnership or even buy-out etc etc. Probably some combination of some of the above. Would you believe a possible timetable for things yet to come? Naw, that is probably too much to hope for.
Ex, what is your source for the 10M number of conversions on those particular 3 days? Maybe it was just shorts?
Don't hold your breath...... But the sooner we start the sooner we finish,
Thanks, I sent a copy to LG and DI, expressing hopes we also do so in the not too distant future. (We need to take care of business first).
some believe these tiny premarket shares are a way to send messages with a pre arranged code. If so, this is easy to mess up cheaply, just buy or sell one or two shares premarket and mess up the message sent.
I too believe they will announce an ASM before year end.
Of course there are differences, a major one is cost. I was making a point about the basic principle. Like I said, aspirin is a a very imperfect comparison. I was just using it to illustrate the basic point I was making.
I have no quarrel with what you wrote. But just imagine if there was no aspirin and it just got invented today, This is a treatment that reduces high fever (among other things). If they now ran trials to put aspirin on the market as a treatment for high fever, would they have to run a separate trial for each indication wherein fever occurs - a very large number of possible causes of fever? Or simply run one large trial looking at fever as a single problem they wish to treat and disregards the differences that may exist for the purposes of this trial. I understand this a very imperfect analogy, but I think it crudely makes the point I wish to make - and not differentiate between a fever in a flu patient versus a fever in say a covid patient or any of the other multitude of causes of fever.
I understand where you are coming from. Sure there will be differences based on the organ in which the cancer finds itself and presumably there may be differences in what is required to treat them. But I suggest it is worth a shot that the similarities IN MOST solid cancers will allow them to be treated by the same PLATFORM without problem even if several may not (or may need some further modification to the same basic protocol). Say some 16 cancer types respond well to this treatment. Why delay approval for use in these 16 cancer types for many, many years?
In separate trial it may take many, many year, at huge cost, and those waiting with type X cancer, may have to wait for 10 to 20 years before we even get to trial for variety X cancer.. There would clearly need to be some sort of follow up procedures to determine which if any cancer types are not responding to this treatment and drop them from the label. But I believe that the greater good is for much more rapid approval and treatment for those cancers that respond well to the treatment (hopefully most solid cancer types)..
I am no expert, but in my lay opinion, only one trial should be needed to gain approval for all solid tumors of any type.
Can we not ignore the differences between the cancer's location and focus on the similarities and design the trial such that say a minimum number of persons will be treated for each named cancer and above that minimum they could enroll any cancer type as may wish treatment to fill the trial. This could simply be thought of as a trial for treatment of "solid cancer," without any further adjectives or sub-categories.
So for example perhaps the trial could name say 20 (not rare) solid cancers, and perhaps have trial size of say 1000. Then they would have to enroll at least say 25 of each of these types of cancer in the trial. That would be 500 patients, and the remaining 500 could be of ANY solid cancer without respect to cancer type.
I would suggest that a good response to this sort of trial should merit a global approval for all solid cancers (even beyond the 20 named cancers) without taking years of trials, and huge expense, for many lengthy trials in every solid cancer type.
I am sure many will say this is not the way of the FDA. And I say why the heck not. If in fact certain cancers will not succumb to the DCVAX treatment that will be seen by following the treatment for the first several years to see if there is no effect on certain cancers. In any case even then at least the DCVAX is safe and does not cause any harm.
But if you are living o a park bench you probably can not afford the longer bolts.
After all, how can you attach a flat park bench to a round Earth?
AEK, I think thet this is not quite right.
Comment 4: Looks like the MOS for rGBM combo patients will be 27 months.
this is really great info, but why the secrecy on the slides????
I don't think so. IMO it is still in the works.
Thanks ATL, this is really cool!! I am wondering if the spike in SP that happened at about 1:15 PM (a little more than an hour after your post) was due to your info.
you left one out from Lykiri:
Long tail (5 years)
LL
"5 years... not just survival but 5 years without recurrence"
what time is LL speaking today and tomorrow? It was to be after hours?
Anyone know why iHub has lost the Message Number column on the far left and now replaced with the Likes column in its place? It is very disorienting.
While I am convinced we are headed to some good news in the near future, and in the end while all good news is "good" some are better than others. Not all the same wrt investors or shorts. But the difference can be day and night for shorts, much more so than for the longs.
From the short perspective, imagine two alternatives for the good news to take. One, they announce very good news in the PIII trial and a good JA and news for a BLA and news for more combo trials and for Direct trials. Two, the announce a buy out say to MRK at X dollars plus Y MRK shares per share of NWBO.
While both are very good for longs, the second path is the kiss of death for all shorts, as there is no way for the shorts to talk down or spin the buyout. They are immediate losers as soon as the news is made known. On the first path for the good news, there is always the possibility to spin the news with lies, and hit pieces and predictions of ultimate failure for a myriad number of reasons they can suggest - even if they are far from the truth. The shorts can live to fight another day. Even if the path one good news causes them some loss = they will fight on. Witness May10 etc.
You need to read more closely. I clearly wrote that IMO it would be the announcement of the ASM before Nov. 20.
IMO, you are totally wrong. They will have an ASM this year. Hopefully one punch of several more before year end and likely before Nov 20 (at least for the announcement so far as ASM is concerned).
This hype is pure fantasy. We will see this fake hype train and then on the other side a lot of fake disappointment at how the share price didn't rise as expected. This whole narrative is fabricated. It isn't based in reality.
Right on.
Gary, I think you are underestimating!
I don't think so. It's all systems go. Shorts better cover.
My guts tells me that November will be nothing burger again. Hoping but not expecting anything but disappointment.
Assuming everything else you said is true, LP isn’t doing crap about that and isn’t coming for anyone.
You honestly think the CEO of the biotech that cracked cancer and has the SOC for all solid tumors is gonna waste their time prosecuting a two bit nobody AF and the second rate media platforms he represents?
If LP is focused on the peasants that are “attacking this stock” at all, that is a huge problem, as it means she doesn’t have anything better to do with her time.
a two bit nobody AF and the second rate media platforms he represents
I meant more than "It couldn’t hurt." I have every hope that this will be the turning point that starts DCVAX on it way to its future and will begin to be recognized by the market in a significant rise in share price that the MMs will not be able to prevent.. This will be the proverbial tiny move from the one yard line into goal - the beginning of the next era of DCVAX..
I am hearing that we should be watching the Liau presentation at SNO which will be about the PIII and to hopefully expect other news in the lead up to that period or there abouts. I am hopeful this will be significant.